Anglo American has pledged USD 3 million of funding at the G20 Business Summit in Seoul in support of increasing access to healthcare in developing economies.

Ms Cynthia Carroll CEO of Anglo American has called on fellow participants of the G20 Business Summit to join the company in pledging USD 1 million per year for the next three years in order to help meet the very significant healthcare challenges in developing economies. This innovative approach builds on the company’s longstanding global leadership in HIV/AIDS and TB prevention, testing, treatment, care and support.

Ms Cynthia Carroll CEO of Anglo American said “I am delighted to lead this initiative with Yasuchika Hasegawa and Takeda Pharmaceutical. Anglo American has a deep understanding of the clear business case for investment in health to promote economic growth in developing economies. We call upon the business community of the G20 to help meet this health challenge by providing the investment required to strengthen healthcare systems in developing countries in order to increase access to better quality healthcare.

She said “Building upon our already extensive work in the field of HIV/AIDS and TB, we have pledged USD 3 million of funding over the next three years to the Global Fund to Fight AIDS, Tuberculosis and Malaria and ask our fellow G20 Business Summit participants to match that commitment. We hope that such action will also act as a catalyst for further similar investments from large companies around the world. Together we can make a real and lasting difference.”

The G20 Business Summit is an unprecedented cooperative effort between the public and private sectors and sees many of the world’s top CEOs engaging in discussion with state leaders ahead of the G20 meeting in Seoul. Anglo American’s Cynthia Carroll is co-convening a panel at the Business Summit, addressing the issue of ‘Increasing access to healthcare in developing economies’.

The G20 Business Summit will host 112 global businesses, representing an asset value of USD 30 trillion and annual sales of USD 4 trillion. It is therefore hoped that the call to action will result in approximately USD 300 million being pledged over the next three years to help tackle the developing world’s healthcare challenges.